000 | 01712 a2200505 4500 | ||
---|---|---|---|
005 | 20250515150250.0 | ||
264 | 0 | _c20090810 | |
008 | 200908s 0 0 eng d | ||
022 | _a1879-1484 | ||
024 | 7 |
_a10.1016/j.atherosclerosis.2008.09.039 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHauer, Arnaud D | |
245 | 0 | 0 |
_aVaccination against TIE2 reduces atherosclerosis. _h[electronic resource] |
260 |
_bAtherosclerosis _cJun 2009 |
||
300 |
_a365-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAtherosclerosis _ximmunology |
650 | 0 | 4 |
_aCollagen _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Vectors |
650 | 0 | 4 | _aImmunity, Cellular |
650 | 0 | 4 | _aImmunization Schedule |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aNeovascularization, Pathologic _ximmunology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aReceptor, TIE-2 _xgenetics |
650 | 0 | 4 |
_aReceptors, LDL _xdeficiency |
650 | 0 | 4 |
_aSalmonella typhimurium _xgenetics |
650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
650 | 0 | 4 |
_aVaccines, DNA _xadministration & dosage |
700 | 1 | _aHabets, Kim L L | |
700 | 1 | _avan Wanrooij, Eva J A | |
700 | 1 | _ade Vos, Paula | |
700 | 1 | _aKrueger, Joerg | |
700 | 1 | _aReisfeld, Ralph A | |
700 | 1 | _avan Berkel, Theo J C | |
700 | 1 | _aKuiper, Johan | |
773 | 0 |
_tAtherosclerosis _gvol. 204 _gno. 2 _gp. 365-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.atherosclerosis.2008.09.039 _zAvailable from publisher's website |
999 |
_c18478930 _d18478930 |